Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05897229

Palliative Care in Patients With COVID-19: Analysis of Costs of Hospitalization in Wards and Intensive Care Units

The confrontation of COVID-19 foreshadowed a serious crisis of scarce health resources worldwide. To assist in this confrontation, the Palliative Care Scientific Technical Core of the Clinical Hospital, School of Medicine, Sao Paulo University (USP) elaborated a Triage Protocol for Palliative Care (PALI-COVID Tool) and it was possible to categorize the patients in three groups, according to the risk of death and needs of Palliative Care (PC), through the clinical evaluation of the patient that also directed them to the hospitalization resource according to their need (ward x ICU).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

The patients grouped as with higher risk of death and PC needs (green group) by PALI-COVID Tool were those with a profile of end-of-life, signs of clinical deterioration and risk of death on admission and thus indicated for admission to the COVID-19 Palliative Care Inpatient Unit, however some were admitted to the ICU. Objective: to analyze the direct costs of hospitalization of COVID-19 Palliative Care patients in Palliative Care Inpatient Unit and ICU screened as green group by the COVID-19 Screening Protocol developed in the institution. Methods: observational, cross-sectional and retrospective study of the service database of patients over 18 years of age screened as the green group (PALI-COVID). The variables to be investigated are related to sociodemographic and clinical data, length of stay and hospitalization scenarios, time to call for PC, outcome and costs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • inpatients with severe forms of COVID-19 between April 08 and July 31, 2020
  • positive reverse-transcriptase polymerase chain reaction (RT-PCR).
  • patients with terminal illness and high clinical risk of death before COVID-19.
  • those admitted to an ICU or palliative care unit.

Exclusion criteria

  • absence of hospitalization cost data in the institution's electronic records

Treatment and study plan

Analysis of costs with patient care during hospitalization

Other

Analysis of direct costs with supplies, medications, diets, laboratory tests and imaging exams, and invasive procedures such as mechanical ventilation, dialysis, and the use of vasoactive drugs.-analysis of costs referring to working hours of physicians, nurses and physical therapists in each unit normalized for the same number of beds.- cost minimization and consequential cost analysis.

Primary outcomes

  1. Direct costs (supplies)

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    costs related to supplies, medications, diets, laboratory tests, imaging exams, and invasive procedures (such as mechanical ventilation, dialysis, and the use of vasoactive drugs). The costs will be calculate for the three groups and compared between them.

  2. Direct costs (working hours)

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    costs referring to working hours of health professionals (physicians, nurses and physical therapists) in each unit normalized for the same number of beds. The costs will be calculate for the three groups and compared between them.

  3. Cost minimization, and consequential cost analysis

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    all the costs will be compared between them to do a cost-effectiveness analysis as the death rate will be probabily similar in the three groups.

Secondary outcomes

  1. Sociodemographic profile

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    age and sex to identify and analyze the profile of the patients included in the study.

  2. Clinical profile

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    diagnosis, underlying disease, comorbidities to identify and analyze the profile of the patients included in the study.

  3. Length of stay and inpatient settings

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    length of stay at Palliative Care unit (PC), ICU and PC & ICU to identify and analyze the profile of the patients included in the study and analyze the costs.

  4. Time to call Palliative Care group

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    admission to the institution, date of call of PC, first assessment of PC, indication of transfer to a COVID-19 PC unit, and date of transfer to PC unit to identify and analyze the time it took for staff to recognize the need for CP for the patients that has repercussions on the cost of hospitalization.

  5. Life-sustaining procedures

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    such as mechanical ventilation, dialysis, and the use of vasoactive drugs to identify and analyze the use of life-sustaining procedures in the study population and analyze the costs.

  6. Inpatient daily rates

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    rates for Palliative Care unit (PC), ICU and PC & ICU to analyze the costs.

  7. Outcome of hospitalization

    Time frame: Hospitalizations between April 8th to July 31th, 2020

    hospital discharge, transference, and death to identify and analyze the profile of the patients included in the study and to make a cost-effectiveness analysis with the all costs that will be analyzed.

Study contacts

Contact information is provided by the study sponsor or research team.

Ednalda M Franck, RN, MSc

CONTACT

[email protected]

+ 55 11 99814-6580

Maria DC Otero Rodriguez, BSc

CONTACT

[email protected]

+ 55 11 2661-2407

Sponsors and collaborators

Lead sponsor

University of Sao Paulo General Hospital

Other

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Jun 9, 2023
Registry last updated
Jun 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.